🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/04/1987 | 8,30 | 8,63 | 8,24 | 8,59 | +3,51% | 4,63% | 12.127.666 |
| 02/04/1987 | 8,29 | 8,35 | 8,29 | 8,30 | +0,32% | 0,72% | 6.919.315 |
| 01/04/1987 | 8,15 | 8,29 | 8,14 | 8,27 | +0,89% | 1,87% | 8.532.187 |
| 31/03/1987 | 8,16 | 8,24 | 8,14 | 8,20 | +1,06% | 1,30% | 9.671.573 |
| 30/03/1987 | 7,98 | 8,24 | 7,98 | 8,11 | -3,70% | 3,32% | 17.668.022 |
| 27/03/1987 | 8,68 | 8,68 | 8,40 | 8,42 | -2,46% | 3,21% | 9.792.302 |
| 26/03/1987 | 8,59 | 8,69 | 8,55 | 8,63 | +1,72% | 1,62% | 12.636.994 |
| 25/03/1987 | 8,62 | 8,62 | 8,49 | 8,49 | -1,69% | 1,54% | 9.233.928 |
| 24/03/1987 | 8,66 | 8,67 | 8,60 | 8,63 | -0,15% | 0,84% | 6.766.517 |
| 23/03/1987 | 8,67 | 8,69 | 8,59 | 8,65 | -0,38% | 1,15% | 10.131.854 |
| 20/03/1987 | 8,48 | 8,68 | 8,45 | 8,68 | +2,58% | 2,74% | 12.669.062 |
| 19/03/1987 | 8,34 | 8,46 | 8,34 | 8,46 | -0,47% | 1,51% | 6.936.293 |
| 18/03/1987 | 8,55 | 8,56 | 8,35 | 8,50 | +0,00% | 2,48% | 10.484.611 |
| 17/03/1987 | 8,23 | 8,51 | 8,20 | 8,50 | +3,30% | 3,78% | 8.881.171 |
| 16/03/1987 | 8,08 | 8,24 | 8,03 | 8,23 | +1,47% | 2,62% | 7.932.312 |
| 13/03/1987 | 8,34 | 8,35 | 8,06 | 8,11 | -2,31% | 3,49% | 11.593.814 |
| 12/03/1987 | 8,38 | 8,40 | 8,28 | 8,30 | -1,10% | 1,42% | 8.571.802 |
| 11/03/1987 | 8,53 | 8,56 | 8,40 | 8,40 | -1,09% | 1,94% | 9.671.573 |
| 10/03/1987 | 8,45 | 8,53 | 8,39 | 8,49 | +0,71% | 1,73% | 7.911.562 |
| 09/03/1987 | 8,51 | 8,51 | 8,34 | 8,43 | -1,70% | 2,10% | 6.636.355 |
| 06/03/1987 | 8,53 | 8,57 | 8,46 | 8,57 | +0,70% | 1,40% | 8.000.222 |
| 05/03/1987 | 8,53 | 8,59 | 8,47 | 8,51 | +1,34% | 1,40% | 10.537.430 |
| 04/03/1987 | 8,32 | 8,46 | 8,24 | 8,40 | +1,12% | 2,63% | 15.206.270 |
| 03/03/1987 | 8,24 | 8,38 | 8,24 | 8,31 | +0,97% | 1,61% | 9.265.997 |
| 02/03/1987 | 8,16 | 8,27 | 8,14 | 8,23 | +0,65% | 1,62% | 7.792.718 |
| 27/02/1987 | 8,12 | 8,19 | 8,06 | 8,18 | +0,65% | 1,63% | 6.679.742 |
| 26/02/1987 | 8,22 | 8,24 | 8,12 | 8,12 | -1,21% | 1,45% | 7.460.712 |
| 25/02/1987 | 8,12 | 8,30 | 8,12 | 8,22 | +1,80% | 2,12% | 9.967.738 |
| 24/02/1987 | 7,90 | 8,14 | 7,90 | 8,08 | +2,78% | 3,02% | 9.207.518 |
| 23/02/1987 | 7,91 | 7,94 | 7,74 | 7,86 | -0,84% | 2,51% | 10.888.301 |